| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sensei Biotherapeutics, Inc. (SNSE) has 9 insiders with recent SEC Form 4 filings, including 18 buys and 0 sells. SNSE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 1.24M | $29.00M | - | |
| ? | 155.6K | $3.64M | - | |
| Other | 80.0K | $1.87M | - | |
| Dir | 23.1K | $540.5K | - | |
| Dir | 19.0K | $444.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2022 | Peyer James | Director, 10% Owner | Buy | 2,500 | $3.60 | $9,000.00 | - | -46.2% | -52.7% | |
| Feb 25, 2022 | Cambrian Biopharma Inc | 10% Owner | Buy | 2,500 | $3.65 | $9,125.00 | - | -54.8% | -60.9% | |
| Feb 25, 2022 | Peyer James | Director, 10% Owner | Buy | 2,500 | $3.65 | $9,125.00 | - | -54.8% | -60.9% | |
| Feb 24, 2022 | Cambrian Biopharma Inc | 10% Owner | Buy | 17,500 | $3.65 | $63,950.00 | +0.2% | -55.7% | -60.1% | |
| Feb 24, 2022 | Peyer James | Director, 10% Owner | Buy | 17,500 | $3.65 | $63,950.00 | +0.2% | -55.7% | -60.1% | |
| Feb 18, 2022 | Cambrian Biopharma Inc | 10% Owner | Buy | 19,949 | $4.02 | $80,187.33 | +0.2% | -60.8% | -62.5% | |
| Feb 18, 2022 | Peyer James | Director, 10% Owner | Buy | 19,949 | $4.02 | $80,187.33 | +0.2% | -60.8% | -62.5% | |
| Feb 16, 2022 | Peyer James | Director, 10% Owner | Buy | 12,551 | $4.19 | $52,641.75 | +0.1% | -60.2% | -66.0% | |
| Feb 16, 2022 | Cambrian Biopharma Inc | 10% Owner | Buy | 12,551 | $4.19 | $52,641.75 | +0.1% | -60.2% | -66.0% | |
| Feb 11, 2022 | Cambrian Biopharma Inc | 10% Owner | Buy | 17,500 | $4.45 | $77,900.00 | +0.2% | -64.1% | -66.2% |